EURETINA: Bayer discusses relevant clinical study results Published 2020-10-01 Download video MP4 360p Recommendations 17:25 Exploring the value of physician assistants in ophthalmology 05:32 EURETINA: Heidelberg promotes “dynamic visualization” of the whole eye 41:06 What is Cervical Stenosis? | Jeffrey Cantor, MD 1:21:29 Sauna Benefits Deep Dive and Optimal Use with Dr. Rhonda Patrick & MedCram 11:07 Expanding role of physician assistants in the ophthalmic field 08:48 EURETINA: Zeiss concentrates on workflow enhancements 1:56:10 Sunlight: Optimize Health and Immunity (Light Therapy and Melatonin) 02:30 Macular Hole Surgery 15:48 Implementing, adapting to protocol changes for clinical practice 10:05 EURETINA: Oertli introduces new products at EURETINA 2020 56:17 Seeing is Believing: A Gene Therapy Success 18:46 Approach to the Exam for Parkinson's Disease 1:01:59 E175 - "CAT"-ASTROPHIC Diagnosis with Addison's Disease 09:52 EURETINA: Distinguished speakers to present challenging cases in two courses 10:16 The Future of AFib Treatment 08:19 EURETINA: Geuder introduces several new products 15:10 Capabilities of telemedicine for ophthalmologists during a pandemic: Part I 05:38 EURETINA: Novel retinal technologies in imaging and disease management 11:25 EURETINA: Oculus prioritizing production lines during pandemic 13:30 Financial planning amid a pandemic: Part II Similar videos 1:20:41 'Management of Proliferative Diabetic Retinopathy in 2021' 01:41 Improving Clinical Trials for Heart Failure Patients 04:02 Efficacy and Safety of Intravitreal Aflibercept Treat and-Extend Regimens 02:10 Rishi Singh: PROMISE Study Results 59:33 EURETINA 2021 - CONTROVERSIES IN LASER TREATMENTS IN 2021 1:18:46 EURETINA Case Club with Prof Frank G. Holz (Dec 9th, 2021) 00:42 Learning from our clinical trials 04:00 Hendrik Scholl, EURETINA 2019 - Latest updates in retinal dystrophies 06:13 Rishi Singh, MD: Comparing Disease Activity with Brolucizumab vs Aflibercept in HAWK and HARRIER 1:00:22 Central Serous Chorioretinopathy (CSC): Shedding an Evidence-Based Light on a Mysterious Disease 05:15 DRCR.net Protocol T study: 1- and 2-year results 51:24 EURETINA Debates: Round 1 - Neovascular AMD 09:11 Eye to Eye: Towards an optimised use of ocular steroids 01:31 Brolucizumab demonstrates drying effect in patients with DME 01:18 Lloyd Clark, MD: Choosing Between Anti-VEGF Therapies 16:03 Retinal Phenotype & Molecular Features of nAMD:AI-Based Big Data Analyses – Oliver Zeitz | ISS 2023 09:54 PIE Talks in Virtual Amsterdam: Jan Voss, VP and Head of Therapeutic Area Ophthalmology 48:44 “Mini-Retina” – A tool to unlock the future of restored vision in retinal blindness More results